Recursion Pharmaceuticals (RXRX) Stock Soars as AI Drug Discovery Hype Returns

TLDR Recursion Pharmaceuticals stock jumped 16% on October 8, 2025, reaching around $6.08 after falling 5.4% the previous day on broader market weakness. The company reported Q2 2025 revenue of $19.2 million (up 33% year-over-year) but posted a net loss of $171.9 million as R&D spending increased. Recursion cut its workforce by 20% in mid-2025 [...]

The post Recursion Pharmaceuticals (RXRX) Stock Soars as AI Drug Discovery Hype Returns appeared first on Blockonomi.